Akan Biosciences
AKAN Biosciences is a biotechnology and cellular therapy company based in Gaithersburg, MD, focused on developing next-generation injectable products to treat degenerative diseases and injuries. With a commitment to improving patients' lives, they leverage advanced tissue engineering and stem cell-based approaches to create innovative therapies for conditions such as osteoarthritis, autism, and rheumatoid arthritis.
The company is recognized for its expertise in creating quality non-expanded adult stem cell-based products for various medical applications. Currently, their product StroMel is undergoing Phase 2 clinical trials for knee osteoarthritis, with additional trials planned for a range of other indications, including wound healing, Crohn's disease, and sports injuries.
Generated from the website


